Evidence map›Paper›PMID 31471947›Full record

ArticleStem cells translational medicine2020

Capillary-resident EphA7

Yuri Yoshida, Maki Kabara, Kohei Kano, Kiwamu Horiuchi, Taiki Hayasaka, Yui Tomita, Naofumi Takehara, Akiho Minoshima, Tatsuya Aonuma, Keisuke Maruyama and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Blood Vessel Resident Human Stem Cells in Health and Disease.Stem cells translational medicine · 2022
    Review
  10. Capillary-resident EphA7Stem cells translational medicine · 2020
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yuri YoshidaDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Maki KabaraDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Kohei KanoDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Kiwamu HoriuchiDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Taiki HayasakaDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Yui TomitaDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Naofumi TakeharaDepartment of Medicine, Division of Cardiovascular, Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Akiho MinoshimaDepartment of Medicine, Division of Cardiovascular, Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Tatsuya AonumaDepartment of Medicine, Division of Cardiovascular, Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Keisuke MaruyamaDepartment of Medicine, Division of Cardiovascular, Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Naoki NakagawaDepartment of Medicine, Division of Cardiovascular, Respiratory and Neurology, Asahikawa Medical University, Asahikawa, Japan.
Nobuyoshi AzumaDepartment of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.
Naoyuki HasebeDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.
Jun-Ichi KawabeDepartment of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, Japan.ORCID 0000-0002-4837-6598
Asahikawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of pericytes (PCs) with multipotency and broad distribution along capillary suggests that microvasculature plays a role not only as a duct for blood fluid transport but also as a stem cell niche that contributes to tissue maintenance and regeneration. The lack of an appropriate marker for multipotent PCs still limits our understanding of their pathophysiological roles. We identified the novel marker EphA7 to detect multipotent PCs using microarray analysis of an immortalized PC library. PCs were isolated from microvessels of mouse subcutaneous adipose tissues, then EphA7

Indexed as

AnimalsCapillariesCell DifferentiationHumansIschemiaMiceMultipotent Stem CellsPericytesReceptor, EphA7Receptor, EphA7angiogenesiscapillarymesenchymal stem cellsneuronal stem cellspericytesperipheral ischemic diseases

Identifiers

PMID31471947
PMCPMC6954719
OpenAlexW2971305829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.